Clinical Trials on Carbon Ion Radiotherapy in United States

Total 10130 results

Patrick Brooks
Missouri State University

Completed

The Effect of Wearing Masks on End-tidal Carbon Dioxide and Pulse Oximetry

Carbon Dioxide

United States
Lara McKenzie

Completed

Emergency Department Brief Intervention to Increase Carbon Monoxide Detector Use (ProjectCODE)

Intervention-carbon Monoxide Alarm + Educational Tool | Control- Usual Care Flyer on Carbon Monoxide

United States
Wake Forest University Health Sciences
Avita Medical

Recruiting

RECELL to Promote Healing Following Carbon Dioxide (CO2) Laser Treatment in Cosmetic Patients

Photoaging | Carbon Dioxide Laser

United States
Nonin Medical, Inc

Completed

Suspected Cases of Carbon Monoxide Poisoning

Carbon Monoxide Intoxication

United States
North Eastern Ohio Gastroenterology and Endoscopy...
Mercy Health Ohio

Unknown

Comparison Air Versus Carbon Dioxide Insufflation in Single Balloon Anterograde Enteroscopy

Carbon Dioxide Insufflation | Anterograde Single Balloon Enteroscopy

United States
Hennepin Healthcare Research Institute

Completed

End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide Poisoning

Carbon Monoxide Exposure

United States
Paul G. Harch, M.D.
Harch Hyperbaric Research Foundation

Unknown

Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning

Neuropsychiatric Sequelae of Carbon Monoxide Poisoning

United States
Fevzi Shakir

Unknown

Standard Carbon Dioxide Gas Versus Heated Humidified Gas in Gynaecological Laparoscopy

Heated Humidified Carbon Dioxide in Gynaecological Laparoscopic Surgery

United Kingdom
University of Wisconsin, Madison

Completed

ATM Variants in Radiotherapy Patients

Radiotherapy

United States
Tulane University

Withdrawn

A Study Utilizing 3D Printing in Patients Undergoing External Beam Radiation Therapy

Radiotherapy

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma

Ann Arbor Stage I Grade 1 Follicular Lymphoma | Ann Arbor Stage I Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 1 Follicular Lymphoma | Ann Arbor Stage II Grade 2 Follicular Lymphoma | Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma | Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma | Ann... and other conditions

United States
St. Louis University

Completed

Interventional Study to Evaluate the Appearance of Surgical Scars After Laser Therapy

Cicatrix | Carbon Dioxide Laser

United States
Washington University School of Medicine

Completed

Palliative Lattice Stereotactic Body Radiotherapy (SBRT)

Cancer | Palliative Radiotherapy

United States
Intermountain Health Care, Inc.

Recruiting

Normal Quantitative EEG (qEEG) Dataset (NormalEEG)

Carbon Monoxide Poisoning

United States
Nonin Medical, Inc

Terminated

Suspected Cases of Carbon Monoxide Poisoning in the ED

Carbon Monoxide Poisoning

United States
Intermountain Health Care, Inc.

Enrolling by invitation

Carbon Monoxide Blood and DNA Biorepository

Carbon Monoxide Poisoning

United States
Nonin Medical, Inc

Completed

Dysfunctional Hemoglobin Pulse Oximetry

Carbon Monoxide Poisoning

United States
Intermountain Health Care, Inc.
Deseret Foundation

Terminated

Outcome Following Carbon Monoxide Poisoning in Children (CO PED)

Carbon Monoxide Poisoning

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lymphoma

Ann Arbor Stage I Grade 1 Follicular Lymphoma | Ann Arbor Stage I Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann... and other conditions

United States
University of Southern California

Completed

Prospective, Non-Randomized Evaluation of Carbon Dioxide Gas as a Contrast Agent in Comparison With Iodinated Contrast in Endovascular Aneurysm Repair

Prospective | Carbon Dioxide | Angiogram | Endovascular Abdominal Aortic Aneurym Repair

United States
John J Freiberger

Terminated

CO as a Stimulant for Mitochondrial Biogenesis in Human Cardiac Muscle

Cardiac Disease | Mitochondrial Biogenesis | Carbon Monoxide

United States
Intermountain Health Care, Inc.
Deseret Foundation

Completed

One vs. Three Hyperbaric Oxygen Treatments for Acute Carbon Monoxide Poisoning (1V3CORCT)

Carbon Monoxide Poisoning

United States
University of Vermont

Unknown

Carbon Monoxide Monitoring and Emergency Treatment (COMET)

Carbon Monoxide Poisoning

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Lenalidomide in Combination With Rituximab in Treating Participants With Stage III/IV Indolent Non-Hodgkin Lymphoma

Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Indolent Adult Non-Hodgkin... and other conditions

United States
Allegheny Singer Research Institute (also known...

Terminated

Evaluation of Mepitel Film® in Preventing Epidermitis in Patients Receiving Radiation Therapy for Breast Cancer

Breast Cancer | Radiotherapy Side Effect | Radiation Dermatitis | Radiotherapy; Complications | Radiotherapy; Adverse Effect, Dermatitis or Eczema | Radiation Burn

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...
Genentech, Inc.; Pharmacyclics LLC.

Recruiting

Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas

Non-Hodgkin's Lymphoma | Indolent Non-hodgkin Lymphoma | Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue | Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage II Nodal Marginal Zone Lymphoma | Ann Abor Stage III B-Cell Non-Hodgkin Lymphoma | Ann Arbor... and other conditions

United States
National Cancer Institute (NCI)
Celgene Corporation

Active, not recruiting

Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma

Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditions

United States
Abramson Cancer Center of the University of Pennsylvania

Withdrawn

Mechanisms and Predictors of Unusual Radiation or Chemotherapy Toxicity

Severe or Mild Toxicity From Radiotherapy and/or Chemotherapy

United States
National Cancer Institute (NCI)

Active, not recruiting

Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma

Ann Arbor Stage III Non-Hodgkin Lymphoma | Ann Arbor Stage IV Non-Hodgkin Lymphoma | Solid Neoplasm

United States
David Bond, MD
Bristol-Myers Squibb

Active, not recruiting

Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma

Diffuse Large B-Cell Lymphoma | Aggressive Non-Hodgkin Lymphoma | Indolent Non-Hodgkin Lymphoma | Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma | High Grade B-Cell Lymphoma, Not Otherwise Specified | Transformed Non-Hodgkin Lymphoma | Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma | Ann Arbor Stage... and other conditions

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular Lymphoma

Grade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 3 Follicular Lymphoma | Ann Arbor Stage...

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Radiation Therapy and Rituximab in Treating Patients With Stage I-II Grade 1 or Grade 2 Follicular Lymphoma

Ann Arbor Stage I Grade 1 Follicular Lymphoma | Ann Arbor Stage I Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 1 Follicular Lymphoma | Ann Arbor Stage II Grade 2 Follicular Lymphoma

United States
National Cancer Institute (NCI)

Completed

Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditions

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI); Janssen, LP

Completed

Ibrutinib in Combination With Rituximab and Lenalidomide in Treating Patients With Previously Untreated, Stage II-IV Follicular Lymphoma or Marginal Zone Lymphoma

CD20 Positive | Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage II Marginal Zone Lymphoma | Ann Arbor Stage III Marginal... and other conditions

United States
Vanderbilt University
Johns Hopkins University

Withdrawn

Feasibility and Safety of Aerobic Exercise for Head and Neck Cancer Patients

Radiotherapy | Head and Neck Neoplasm

United States
M.D. Anderson Cancer Center

Recruiting

ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Richter Syndrome | Refractory Mantle Cell Lymphoma | Refractory Aggressive B-Cell Non-Hodgkin Lymphoma | Refractory High Grade B-Cell Lymphoma | Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory... and other conditions

United States
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Parsaclisib With or Without Polatuzumab Vedotin Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma

Diffuse Large B-Cell Lymphoma | Indolent Non-Hodgkin Lymphoma | Ann Arbor Stage II Diffuse Large B-Cell Lymphoma | Ann Arbor Stage III Diffuse Large B-Cell Lymphoma | Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | High Grade... and other conditions

United States
The University of Texas Health Science Center,...

Completed

Analysis of Emergency Department (ED) Volumes During Natural Disasters

Dialysis | Carbon Monoxide Poisoning | Trauma Related Injuries

United States
North Carolina Agriculture & Technical State University

Completed

Scavenging of Reactive Carbonyl Species by Dietary Flavonoids in Humans

Polyphenols | Human Health | Reactive Carbonyl Species

United States
University of Washington
National Cancer Institute (NCI); National Comprehensive Cancer Network

Terminated

Enzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Recurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma | Ann Arbor Stage I Mantle Cell Lymphoma | Ann Arbor Stage II Mantle Cell Lymphoma | Ann Arbor Stage III Mantle Cell Lymphoma | Ann Arbor Stage IV Mantle Cell Lymphoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Obinutuzumab and Lenalidomide in Treating Patients With Previously Untreated Stage II-IV Grade 1-3a Follicular Lymphoma

Fatigue | Weight Loss | Fever | Splenomegaly | Ann Arbor Stage II Grade 1 Follicular Lymphoma | Ann Arbor Stage II Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1... and other conditions

United States
Institute of Cancer Research, United Kingdom
Royal Marsden NHS Foundation Trust; Cambridge University Hospitals NHS Foundation...

Completed

Quantification of Breast RadioTherapy Associated Late Toxicity Using Novel UltraSound Techniques (QuaRTUS)

Breast Radiotherapy Toxicity

United Kingdom
M.D. Anderson Cancer Center

Recruiting

PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy (PACIFIC)

Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Ann Arbor Stage II Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Ann Arbor Stage III Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Ann Arbor Stage IV Primary Mediastinal (Thymic) Large B-Cell Lymphoma

United States
The Christie NHS Foundation Trust

Active, not recruiting

Bone Toxicity Following Pelvic Radiotherapy (RadBone)

Gynecologic Cancer | Radiotherapy Side Effect | Fracture

United Kingdom
Bryan Allen
National Cancer Institute (NCI); Holden Comprehensive Cancer Center

Recruiting

T2* MRI Analysis for Sarcoma

Sarcoma | Magnetic Resonance Imaging | Radiotherapy

United States
Midwestern Regional Medical Center

Withdrawn

Stromal Vascular Fraction for Treatment of Xerostomia

Xerostomia Due to Radiotherapy (Disorder)

United States
Joseph Tuscano
National Cancer Institute (NCI); Genentech, Inc.; Pharmacyclics LLC.

Recruiting

Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma

Ann Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma

United States
National Cancer Institute (NCI)

Active, not recruiting

Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Ann Arbor Stage III Non-Hodgkin Lymphoma | Ann Arbor Stage IV Non-Hodgkin Lymphoma | Ann Arbor Stage II Non-Hodgkin Lymphoma

United States
Abramson Cancer Center of the University of Pennsylvania

Completed

A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy

Head and Neck Cancer | Colorectal Cancer | Gastrointestinal Cancer | Biopsy Proven Non Small Cell Lung Cancer | Rectal Cancers | Gynecological Malignancy Requiring Definitive Radiotherapy

United States
Academic and Community Cancer Research United
National Cancer Institute (NCI)

Active, not recruiting

Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma

Ann Arbor Stage III Hodgkin Lymphoma | Ann Arbor Stage IIIA Hodgkin Lymphoma | Ann Arbor Stage IIIB Hodgkin Lymphoma | Ann Arbor Stage IV Hodgkin Lymphoma | Ann Arbor Stage IVA Hodgkin Lymphoma | Ann Arbor Stage IVB Hodgkin Lymphoma | Classic Hodgkin Lymphoma | Ann Arbor Stage IB Hodgkin Lymphoma | Ann... and other conditions

United States

Clinical Trials on Carbon Ion Radiotherapy in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations